Stemnovate
Stemnovate develops multi-organ modeling platforms for drug discovery, utilizing in vitro cell culture and digital karyotyping to assess drug metabolism and toxicity. The company addresses the need for safer clinical trials and improved patient outcomes, particularly for rare diseases in children.
- Biotechnology
Updated 23 months ago
Funding
Raised to date
$1.2MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- Stemnovate develops multi-organ modeling platforms for drug discovery, utilizing in vitro cell culture and digital karyotyping to assess drug metabolism and toxicity. The company addresses the need for safer clinical trials and improved patient outcomes, particularly for rare diseases in children.